Health Canada
www.hc-sc.gc.ca
Common menu bar links
Drugs and Health Products
For Health Professionals - 2010
December
- Thelin (sitaxsentan sodium) - Worldwide Product Withdrawal - Pfizer Canada Inc.
- For Health Professionals [2010-12-20]
- For the Public [2010-12-20]
- “Fat Burner No. 1” (“Qian Mei Yin Zi”): Unauthorized Chinese herbal weight loss product may pose serious health risks
[2010-12-01] - Darvon-N (dextropropoxyphene) - Recall and Withdrawal in Canada - Paladin Labs Inc.
- For Health Professionals [2010-12-01]
- For the Public [2010-12-01]
November
- AVANDIA, AVANDAMET and AVANDARYL - Important New Restrictions on the Use of Rosiglitazone Products Due to Information on Cardiovascular Related Events - GlaxoSmithKline Inc.
- For Health Professionals [2010-11-18]
- For the Public [2010-11-18]
- INVIRASE (saquinavir mesylate) - Need for electrocardiogram monitoring in patients - Hoffmann-La Roche Limited
- For Health Professionals [2010-11-02]
- For the Public [2010-11-02]
October
- Emo-Cort (hydrocortisone) 2.5% Lotion - Recall of Lot 5R6, due to mould contamination - GlaxoSmithKline
- For Health Professionals [2010-10-29]
- Health Canada Information Update [2010-10-29]
- Important Information Regarding the Voluntary Recall of the Children's Product: Hyland's Teething Tablets [2010-10-28]
- Level 1 Normothermic I.V. Fluid Administration Sets (Product Codes D-60 HL and DI-60 HL) heat exchanger assembly manufacturing issue - Recall - Smiths Medical Canada Limited
- Notice to Hospitals [2010-10-22]
- Excelsior Disposable SYRINGE W/Normal Saline (0.9% Sodium Chloride) - Recall - Healthmark
- For Health Professionals [2010-10-19]
- For the Public [2010-10-19]
- Innohep (tinzaparin sodium) - Updated Safety Information on Use in Elderly Patients with Renal Impairment - LEO Pharma Inc.
- For Health Professionals [2010-10-19]
- For the Public [2010-10-19]
- Meridia (sibutramine) Capsules - Voluntary Withdrawal from the Canadian Market - Abbott Laboratories, Limited
- For Health Professionals [2010-10-18]
- Information Update [2010-10-18]
- Pegetron - Important Information Regarding Quality, Safety and Supply - Merck Frosst Canada Ltd.
- For the Public [2010-10-15]
- For Health Professionals [2010-10-12]
- Safety Review of Bisphosphonate Drugs and the Possible Risk of Rare but Serious Thigh Bone Fractures [2010-10-14]
- Alaris PC unit (model 8000) - Total Bolus Display Error - CareFusion
- Notice to Hospitals [2010-10-14]
- ACLASTA (zoledronic acid 5mg/100mL) solution for intravenous infusion - Association with renal dysfunction - Novartis Pharmaceuticals Canada Inc.
- For Health Professionals [2010-10-14]
- For the Public [2010-10-14]
- Update: All marketed sibutramine drugs voluntarily withdrawn in Canada [2010-10-13]
- Abbott Laboratories Voluntarily Withdraws Weight-loss Drug Sibutramine (Meridia®) from the Canadian Market [2010-10-08]
September
- ACTEMRA (tocilizumab) - Risk of Fatal Anaphylaxis - Hoffmann-La Roche Limited
- For Health Professionals [2010-09-17]
- For the Public [2010-09-17]
- Unauthorized Health Product: "E.O.D. Erection on Demand" May Pose Serious Health Risks [2010-09-13]
- Gemstar Pump Sets - Recall - Hospira Healthcare Corporation
- For Health Professionals [2010-09-08]
August
- Gemstar Pump Sets - Recall - Hospira Healthcare Corporation
- For Health Professionals [2010-09-08]
-
Droperidol Injection USP - Association with Severe Arrhythmia - Sandoz Canada Inc.
- For Health Professionals [2010-08-30]
- Delivery of Topical Hemostatic Agents Using Spray Devices - Association with Air/Gas Embolism
- Notice to Hospitals [2010-08-27]
- Important Diabetes Information: GlucaGen Hypokit being Recalled in Canada [2010-08-25]
- AVASTIN (bevacizumab) - Association with Allergic Reactions - Hoffmann-La Roche Limited
- For Health Professionals [2010-08-23]
- For the Public [2010-08-23]
- Adrenalin (epinephrine chloride 1:1000) Intended for Topical Use - Risk of Inadvertent Injection - Erfa Canada Inc.
- For Health Professionals [2010-08-17]
- Notice to Hospitals [2010-08-17]
- RELISTOR (methylnaltrexone bromide) Subcutaneous Injection - Association with gastrointestinal perforation - Wyeth Canada
- For Health Professionals [2010-08-03]
- For the Public [2010-08-03]
July
- RotaTeq - Presence of Porcine Circovirus (PCV) DNA - Merck Frosst Canada Ltd.
- For Health Professionals [2010-07-30]
- Rotarix - Presence of Porcine Circovirus Type 1 (PCV-1) - GlaxoSmithKline Inc.
- For Health Professionals [2010-07-30]
- Unauthorized Health Products Sold by Marigold Natural Pharmacy Ltd. May Pose Health Risks [2010-07-23]
- Status of rosiglitazone drugs in Canada (Avandia, Avandamet, and Avandaryl) [2010-07-08]
June
- Proper Dosing of Liquid Vitamin D Supplements in Infants [2010-06-17]
- MIRENA (Levonorgestrel-Releasing Intrauterine System) - Potential Risk of Uterine Perforation - Bayer Inc.
- For Health Professionals [2010-06-17]
- For the Public [2010-06-17]
- CANCIDAS (caspofungin acetate for injection) - Voluntary Product Recall - Merck Frosst Canada Ltd.
- Notice to Hospitals [2010-06-15]
- Baxter Colleague Volumetric Infusion Pumps - Information for Canadian health care facilities related to the recall in the United States
- Notice to Hospitals [2010-06-11]
- CIPROFLOXACIN INJECTION - Voluntary Recall - BioSyent Pharma Inc.
- Notice to Hospitals [2010-06-09]
- CHAMPIX (varenicline tartrate) - Changes to the Canadian Product Monograph - Pfizer Canada Inc.
- For Health Professionals [2010-06-03]
- For the Public [2010-06-03]
May
- RISPERDAL CONSTA (risperidone powder for injectable prolonged-release suspension) - Needle Detachments Associated with the Needle Assembly Used for Gluteal Injection - Janssen-Ortho Inc.
- For Health Professionals [2010-05-25]
- TYSABRI (natalizumab) - New Safety Information Regarding Progressive Multifocal Leukoencephalopathy (PML) - Biogen Idec Canada Inc.
- For Health Professionals [2010-05-17]
- For the Public [2010-05-17]
- Maalox Multi Action (bismuth subsalicylate) - Confusion with Other Maalox Liquid Products - Novartis Consumer Health Canada Inc.
- For Health Professionals [2010-05-17]
- For the Public [2010-05-17]
- Cuffed Shiley Tracheostomy Products - Health Canada Endorsed Important Safety Information - Tyco Healthcare Canada
- Notice to Hospitals [2010-05-13]
- Updated Information Regarding Recalled Infant and Children Motrin and Tylenol Products [2010-05-10]
- Important Information Regarding Rotavirus Vaccines: Rotarix and RotaTeq [2010-05-07]
- Exelon Patch (rivastigmine transdermal patch) - Serious Adverse Events Related to Medication Errors/Misuse - Novartis Pharmaceuticals Canada Inc.
- For Health Professionals [2010-05-05]
- For the Public [2010-05-05]
April
- Updated Safety Information for Promethazine Hydrochloride Injection [2010-04-26]
- Invirase (saquinavir mesylate) - Association with Dose-Dependent Abnormal Electrical Activity or Conduction in the Heart (Prolongations of QT and PR Intervals) in Healthy Volunteers - Hoffmann-La Roche Limited
- For Health Professionals [2010-04-20]
- For the Public [2010-04-20]
- New Expiry Date for Unused Adjuvanted H1N1 Vaccine (Arepanrix) [2010-04-09]
- Zeftera (ceftobiprole medocaril) for Injection - Discontinuation of Sale - Janssen-Ortho Inc.
- Notice to Hospitals [2010-04-08]
March
- WinRho SDF (Rho(D) Immune Globulin (Human)) - Association with Intravascular Hemolysis in the Treatment of Immune Thrombocytopenic Purpura (ITP) - Important New Prescribing Information - Cangene Corporation
- Notice to Hospitals [2010-03-24]
- For the Public [2010-03-24]
- Fentanyl Transdermal Systems - New Changes to the Dose Conversion Guidelines - Janssen-Ortho Inc., Cobalt Pharmaceuticals Inc., Teva Canada Limited, Ranbaxy Pharmaceuticals Canada Inc., ratiopharm inc., Sandoz Canada Inc. and Pharmascience Inc.
- For Health Professionals [2010-03-10]
- Notice to Hospitals [2010-03-10]
- For the Public [2010-03-10]
February
- Poli-Grip - Association of Long-Term, Excessive Use of Zinc-Containing Poli-Grip Products with Myeloneuropathy and Blood Dyscrasias - GlaxoSmithKline
- For Health Professionals [2010-02-23]
- For the Public [2010-02-23]
- Nipro GlucoPro Insulin Syringes - Recall - Surgo Surgical Supply
- For Health Professionals [2010-02-19]
- For the Public [2010-02-19]
- Accutane (isotretinoin) - Association with Cases of Severe Skin Reactions - Hoffmann-La Roche Limited
- For Health Professionals [2010-02-16]
- For the Public [2010-02-16]
- Surgical Mesh - Complications Associated with Transvaginal Implantation of Surgical Mesh for the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse
- Notice to Hospitals [2010-02-05]
January
- Important Information Concerning Medication for Parkinson's Disease [2010-01-27]
- OPTIMARK (gadoversetamide injection) - Association with Nephrogenic Systemic Fibrosis (NSF) in Patients with Renal Impairment - Tyco Healthcare (Covidien)
- For Health Professionals [2010-01-12]
- For the Public [2010-01-12]
- BiCNU (carmustine for injection) - Type I recall due to Risk of Infection - Bristol-Myers Squibb Canada
- Notice to Hospitals [2010-01-05]
